Labeling fibrin fibers with beads alter single fibrin fiber lysis, external clot lysis, and produce large fibrin aggregates upon lysis.


Journal

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
ISSN: 1473-5733
Titre abrégé: Blood Coagul Fibrinolysis
Pays: England
ID NLM: 9102551

Informations de publication

Date de publication:
01 Oct 2022
Historique:
pubmed: 15 7 2022
medline: 19 10 2022
entrez: 14 7 2022
Statut: ppublish

Résumé

Fluorescent beads are often used as a tool for visualizing fibrin fibers in single fiber mechanics studies and studies of single fiber lysis. Here we investigate the effect of beads on fibrin fiber lysis and extensibility to enhance understanding of this common research technique. We selected beads of the same diameter as those used in previous studies, as well as, beads of similar size to microparticles in the bloodstream. We used fluorescence microscopy, atomic force microscopy (AFM), and scanning electron microscopy (SEM) to quantify changes in fiber lysis, fiber extensibility, and clot structure in the presence and absence of beads. Fibrin clot structure and lysis were altered in the presence of beads. Fibrin clots formed with beads had a higher fiber density, smaller diameter fibers, and smaller pores. The rate of lysis for clots was reduced when beads were present. Lysis studies of bead-labeled individual fibers showed that beads, at concentrations similar to those reported for microparticles in the blood, cause a subset of fibers to resist lysis. In the absence of beads, all fibers lyse. These results demonstrate that beads alter fiber lysis through both a change in fibrin clot structure as well as changes to individual fiber lysis behavior. Additionally, the lysis of clots with beads produced large fibrin aggregates. This data encourages researchers to use careful consideration when labeling fibrin fibers with fluorescent beads and suggests that particles binding fibrin(ogen) in the bloodstream may be an underappreciated mechanism increasing the risk of thrombosis.

Identifiants

pubmed: 35834714
doi: 10.1097/MBC.0000000000001150
pii: 00001721-202210000-00002
doi:

Substances chimiques

Fibrin 9001-31-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

364-371

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Références

Longstaff C. Measuring fibrinolysis: from research to routine diagnostic assays. J Thromb Haemost 2018; 16:652–662.
Chapin JC, Hajjar KA. Fibrinolysis and the control of blood coagulation. Blood Rev 2015; 29:17–24.
Weisel JW, Veklich Y, Collet J-P, Francis CW. Structural studies of fibrinolysis by electron and light microscopy. Thromb Haemost 1999; 82:277–282.
Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, Weisel JW. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy, arteriosclerosis. Thromb Vasc Biol 2000; 20:1354–1361.
Weisel JW. Structure of fibrin: impact on clot stability. J Thromb Haemost 2007; 5: (Suppl 1): 116–124.
Bucay I, O’Brien ET III, Wulfe SD, Superfine R, Wolberg AS, Falvo MR, Hudson NE. Physical determinants of fibrinolysis in single fibrin fibers. PLoS One 2015; 10:e0116350.
Li W, Lucioni T, Li R, Bonin K, Cho SS, Guthold M. Stretching single fibrin fibers hampers their lysis. Acta Biomater 2017; 60:264–274.
Liu W, Carlisle CR, Sparks EA, Guthold M. The mechanical properties of single fibrin fibers. J Thromb Haemost 2010; 8:1030–1036.
Helms CC, Ariëns RAS, de Willige SU, Standeven K F, Guthold M. α−α cross-links increase fibrin fiber elasticity and stiffness. Biophys J 2012; 102:168–175.
Houser JR, Hudson NE, Ping L, O’Brien Iii ET, Superfine R, Lord ST, Falvo MR. Evidence that alphaC region is origin of low modulus, high extensibility and strain stiffening in fibrin fibers. Biophys J 2010; 99:3038–3047.
Li W, Sigley J, Baker S, Guthold M, Brubaker P, Pieters M. Effect of disease and acute exercise on single fibrin fiber properties. Biophys J 2013; 104: (2 Suppl 1): 513a.
Carlisle CR, Sparks EA, Der Loughian C, Guthold M. Strength and failure of fibrin fiber branchpoints. J Thromb Haemost 2010; 8:1135–1138.
Arraud N, Linares R, Tan S, Gounou C, Pasquet J-M, Mornet S, Brisson AR. Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J Thromb Haemost 2014; 12:614–627.
Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJP, Hole P, et al. Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis, nanomedicine: nanotechnology. Biol Med 2011; 7:780–788.
Chandler WL, Yeung W, Tait JF. A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer. J Thromb Haemost 2011; 9:1216–1224.
Chandler WL. Measurement of microvesicle levels in human blood using flow cytometry. Cytometry B Clin Cytom 2016; 90:326–336.
Falvo MR, Millard D, O’Brien ET, Superfine R 3rd, Lord ST. Length of tandem repeats in fibrin's alphaC region correlates with fiber extensibility. J Thromb Haemost 2008; 6:1991–1993.
Hudson NE, Houser JR, O’Brien ET, Taylor RM 3rd, Superfine R 2nd, Lord ST, Falvo MR. Stiffening of individual fibrin fibers equitably distributes strain and strengthens networks. Biophys J 2010; 98:1632–1640.
Cone SJ, Fuquay AT, Litofsky JM, Dement TC, Carolan CA, Hudson NE. Inherent fibrin fiber tension propels mechanisms of network clearance during fibrinolysis. Acta Biomater 2020; 107:164–177.
Zubairova LD, Nabiullina RM, Nagaswami C, Zuev YF, Mustafin IG, Litvinov RI, Weisel JW. Circulating microparticles alter formation, structure, and properties of fibrin clots. Sci Rep 2015; 5:17611.
Collet J-P, Lesty C, Montalescot G, Weisel JW. Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots ∗. J Biol Chem 2003; 278:21331–21335.
Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, Weisel JW. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed, arteriosclerosis. Thromb Vasc Biol 2000; 20:1354–1361.

Auteurs

Najnin Rimi (N)

Physics Department, University of Richmond, Richmond, Virginia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH